Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
2011
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
2006
The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
2019
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Neutrophils at work
2014 Standout
Aspergilluspetrous apicitis associated with cerebral and peritubular abscesses in an immunocompetent man
2013
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Advances in stem cell mobilization
2012
Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies
2010
The Transplantation of Hematopoietic Stem Cells After Non-Myeloablative Conditioning: A Cellular Therapeutic Approach to Hematologic and Genetic Diseases
2003
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
2004
Therapy for fungal diseases: opportunities and priorities
2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
2010
Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
2007
Mobilization and collection of peripheral blood progenitor cells for transplantation
2005
Methods for in vitro evaluating antimicrobial activity: A review
2015 Standout
Risk assessment in haematopoietic stem cell transplantation: Stem cell source
2007
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
2010
Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
2006
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
2011
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Immune reconstitution following hematopoietic stem-cell transplantation
2007
Graft-versus-host disease
2009 Standout
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial
2004
Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
2014
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
2006
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Candida glabrata Endophthalmitis Treated Successfully with Caspofungin
2005
Hematopoietic Stem-Cell Transplantation
2006 Standout
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
2010
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
2013
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
2015
Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation
2004
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
2004
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
2009
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
2012
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
2004
Risk stratification for invasive aspergillosis in immunocompromised patients
2012
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
2006
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
2010
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
2004
Biological effects of essential oils – A review
2007 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
2012
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
2009
Antibody-Mediated Encephalitis
2018 Standout
Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
2012
Acute Myeloid Leukemia
2015 Standout
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
2016
Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
2017
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
AspergillusInfections in Transplant Recipients
2005
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
2020
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
2020
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Is universal antifungal prophylaxis mandatory in lung transplant patients?
2013
Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread
2011
Assessment of Efficacy of Antifungals against Aspergillus fumigatus: Value of Real-Time Bioluminescence Imaging
2013
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy
2003
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer‐Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
2013
Susceptibility of Drug-Resistant Clinical Herpes Simplex Virus Type 1 Strains to Essential Oils of Ginger, Thyme, Hyssop, and Sandalwood
2007
Works of Karin Bilger being referenced
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
2003
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
2013
HSV excretion after bone marrow transplantation: a 4-year survey
2004
Sequential FDG PET and MRI Findings in a Case of Human Herpes Virus 6 Limbic Encephalitis
2012
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient
2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
2003
Genetic Characterization of Thymidine Kinase from Acyclovir‐Resistant and ‐Susceptible Herpes Simplex Virus Type 1 Isolated from Bone Marrow Transplant Recipients
2000
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
2010
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
2003
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
2008
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen
2003
Allogeneic Hematopoietic Stem-Cell Transplantation After Nonmyeloablative Preparative Regimens: Impact of Pretransplantation and Posttransplantation Factors on Outcome
2001
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
2016